Total Payments
$14,674
2024 Payments
$1,016
Companies
46
Transactions
144
Medicare Patients
6,058
Medicare Billing
$4.6M
Payment Breakdown by Category
Food & Beverage$8,604 (58.6%)
Consulting$3,500 (23.9%)
Other$2,000 (13.6%)
Travel$570.35 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,604 | 138 | 58.6% |
| Consulting Fee | $3,500 | 1 | 23.9% |
| Honoraria | $2,000 | 1 | 13.6% |
| Travel and Lodging | $570.35 | 4 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $5,696 | 27 | $0 (2024) |
| Novocure Inc. | $2,218 | 4 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $826.22 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $694.13 | 9 | $0 (2024) |
| GENZYME CORPORATION | $657.58 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $525.12 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $359.01 | 6 | $0 (2023) |
| TESARO, Inc. | $354.45 | 3 | $0 (2019) |
| Amgen Inc. | $344.86 | 7 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $327.05 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,016 | 26 | E.R. Squibb & Sons, L.L.C. ($420.20) |
| 2023 | $530.86 | 22 | Janssen Biotech, Inc. ($121.13) |
| 2022 | $515.28 | 14 | GENZYME CORPORATION ($137.54) |
| 2021 | $211.57 | 4 | GlaxoSmithKline, LLC. ($100.00) |
| 2020 | $646.59 | 7 | Eisai Inc. ($125.00) |
| 2019 | $1,738 | 17 | Bayer HealthCare Pharmaceuticals Inc. ($446.55) |
| 2018 | $2,173 | 26 | Bayer HealthCare Pharmaceuticals Inc. ($630.81) |
| 2017 | $7,843 | 28 | Bayer HealthCare Pharmaceuticals Inc. ($4,279) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $382.82 | General |
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $120.20 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: BioOncology | ||||||
| 05/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: HEMATOLOGY | ||||||
| 01/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,323 | 7,596 | $4.1M | $1.0M |
| 2022 | 27 | 1,483 | 6,327 | $3.6M | $965,326 |
| 2021 | 24 | 1,541 | 7,438 | $4.4M | $1.2M |
| 2020 | 26 | 1,711 | 8,164 | $5.0M | $1.4M |
Total Patients
6,058
Total Services
29,525
Medicare Billing
$4.6M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 61 | 1,521 | $1.7M | $395,649 | 23.6% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 58 | 1,451 | $599,263 | $128,578 | 21.5% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 63 | 65 | $343,200 | $86,110 | 25.1% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 37 | 392 | $205,800 | $66,844 | 32.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 102 | 469 | $187,600 | $65,383 | 34.9% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 16 | 269 | $127,775 | $45,669 | 35.7% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 12 | 52 | $161,200 | $37,733 | 23.4% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 63 | 97 | $114,751 | $33,023 | 28.8% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 114 | 323 | $96,900 | $29,687 | 30.6% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 111 | 410 | $82,000 | $25,169 | 30.7% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 48 | 51 | $61,710 | $16,366 | 26.5% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 92 | 303 | $49,995 | $14,566 | 29.1% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 102 | 107 | $35,310 | $13,412 | 38.0% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 11 | 11 | $67,551 | $12,670 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $29,700 | $10,422 | 35.1% |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Office | 2023 | 14 | 186 | $50,220 | $10,416 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 168 | $27,720 | $10,184 | 36.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 40 | 49 | $29,400 | $9,630 | 32.8% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 24 | 25 | $36,300 | $8,834 | 24.3% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 14 | 124 | $33,480 | $6,769 | 20.2% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 11 | 12 | $16,236 | $5,759 | 35.5% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Office | 2023 | 26 | 27 | $17,550 | $5,720 | 32.6% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 15 | 15 | $15,450 | $4,541 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $8,250 | $2,684 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $7,150 | $2,144 | 30.0% |
About Dr. Binh Tran, MD
Dr. Binh Tran, MD is a Radiation Oncology healthcare provider based in Mishawaka, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184610602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Binh Tran, MD has received a total of $14,674 in payments from pharmaceutical and medical device companies, with $1,016 received in 2024. These payments were reported across 144 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,604).
As a Medicare-enrolled provider, Tran has provided services to 6,058 Medicare beneficiaries, totaling 29,525 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Mishawaka, IN
- Active Since 09/20/2005
- Last Updated 01/03/2018
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1184610602
Products in Payments
- Xofigo (Drug) $5,519
- Optune (Device) $2,218
- JEVTANA (Drug) $557.58
- TAGRISSO (Drug) $366.06
- ZEJULA (Drug) $354.45
- Erleada (Drug) $348.48
- XTANDI (Drug) $301.04
- OPDIVO (Biological) $276.87
- XGEVA (Biological) $250.00
- LYNPARZA (Drug) $249.98
- LIBTAYO (Biological) $193.68
- Nubeqa (Drug) $177.11
- KEYTRUDA (Biological) $174.73
- ERLEADA (Drug) $167.05
- DARZALEX (Biological) $152.00
- Lenvima (Drug) $148.16
- Xtandi (Drug) $138.64
- Bavencio (Drug) $124.99
- EMPLICITI (Biological) $124.99
- Yescarta (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.